Considerations when selecting a treatment schedule for people with T2D include patient preference (for example, for fewer injections or a simpler regimen), variability in meal patterns or daily routine (necessitating a flexible dosing schedule), and a need for better PPG control (by addition of a rapid-acting insulin either as part of a basal-bolus or premixed insulin or IDegAsp treatment regimen). Here, INS is linked to type 2 diabetes mellitus.